The excess cost associated with healthcare-associated bloodstream infections at Auckland City Hospital

New Zealand Medical Journal

Volumn 123, Issue 1324, 2010, Pages 17-24

  Burns, Andrew ^a   Bowers, Lesley ^a   Pak, Nick ^a   Wignall, Jean ^a   Roberts, Sally ^a  

^a AUCKLAND DISTRICT HEALTH BOARD   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BLOODSTREAM INFECTION; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HEALTH CARE COST; HEMODIALYSIS; HOSPITAL ADMISSION; HUMAN; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; RENAL REPLACEMENT THERAPY; BACTEREMIA; COMPARATIVE STUDY; CROSS INFECTION; ECONOMICS; FOLLOW UP; HEALTH SERVICES RESEARCH; HOSPITAL; HOSPITAL COST; INCIDENCE; LENGTH OF STAY; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

BACTEREMIA; CROSS INFECTION; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HEALTH SERVICES RESEARCH; HOSPITAL COSTS; HOSPITALS, URBAN; HUMANS; INCIDENCE; LENGTH OF STAY; MALE; MIDDLE AGED; NEW ZEALAND; RETROSPECTIVE STUDIES;

EID: 77958074342     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Plowman R, Graves N, Griffin MAS, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect 2001;47:198-209.
2. Roberts RR, Scott RD, Cordell R, et al. The use of economic modelling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis 2003;36:1424-52.
3. Graves N, Nicholls TM, Wong CGS, Morris AJ. The prevalence and estimates of the cumulative incidence of hospital-acquired infections among patients admitted to Auckland District Health Board Hospitals in New Zealand Infect Control Hosp Epidemiol 2003;24:56-61.
4. Graves N, Nicholls TM, Morris AJ. Modelling the costs of hospital-acquired infections in New Zealand. Infect Control Hosp Epidemiol 2003;24:214-223.
5. The Australian Council on Healthcare Standards; Infection Control Indicators, Clinical Indicators Users' Manual. Version 3, 2005. ACHS Performance and Outcomes Service, Ultimo, NSW, Australia.
6. Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol 2002;23:190-7.
7. Upton A, Smith P, Roberts SA. Excess cost associated with Staphylococcus aureus poststernotomy mediastinitis. N Z Med J 2005;118:1210(1316). http://www.nzmj.com/journal/118-1210/1316/content.pdf
8. Anderson DJ, Kirkland KB, Kaye KS, et al. Underresourced hospital infection control and prevention programs: penny wise, pound foolish? Infect Control Hosp Epidemiol 2007;28:767-773.
9. Roberts RR, Frutos PW, Ciavarella GG et al Distribution of variable vs fixed costs of hospital care. JAMA 1999;218:644-9
10. Engemann JJ, Friedman JY, Reed SD, et al Clinical outcomes and costs due to Staphylococcus aureus bacteremia among patients receiving long-term hemodialysis. Infect Control Hosp Epidemiol 2005;26:534-539.
11. Lodoise PL, Mckinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteraemia. Diagn Microbiol Infect Dis 2005;52:113-22.
12. Blot SI, Depuydt P, Annemans L, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis 2005;41:1591-8.
13. Shannon RP, Patel B, Cummins D, et al. Economics of central line-associated bloodstream infections. Am J Med Quality. 2006;21(6) Suppl:7-15.
14. Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infections in Argentina: a prospective, matched analysis. Am J Infect Control 2003;31;475-80.
15. McHugh CG, Riley LW. Risk factors and costs associated with methicillin-resistant Staphylococcus aureus bloodstream infections. Infect Control Hosp Epidemiol 2004;25:425-430.
16. Provonost P, Needham D, Berenholtz S, et al An intervention to decrease catheter-related bloodstream infections in ICU. N Eng J Med 2006:355:2725-32.
17. Pittet D, Hugonnet S, Harbarth S, et al and members of the Infection Control Programme. Effectiveness of a hospital-wide programme to improve compliance with hand hygiene. Lancet 2000;356:1307-12.
18. Grayson ML, Jarvie LJ, Martin R, et al Significant reductions in methicillin-resistant Staphylococcus aureus bacteraemia and clinical isolates associated with a multisite, hand hygiene culture-change program and subsequent statewide roll-out. Med J Aust 2008;188:633-40.
19. Graves N. Economics and preventing hospital-acquired infection. Emerg Infect Dis 2004;10:561-6.
20. Graves N, Harbath S, Beyersmann J, et al. Estimating the cost of healthcare-associated infections: mind your p's and q's. Clin Infect Dis 2010;50:1017-21.
21. Infection Prevention and Control. Hand Hygiene New Zealand. http://www.infectioncontrol.org.nz/handhygiene/home.htm
22. Infection Prevention and Control. Guidance for New Zealand hospitals: Preventing central venous catheter-related bloodstream infections. http://www.infectioncontrol.org.nz/catheter related/home.htm